<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://eln.excellgen.com/index.php?action=history&amp;feed=atom&amp;title=Peptides_for_Transfection</id>
	<title>Peptides for Transfection - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://eln.excellgen.com/index.php?action=history&amp;feed=atom&amp;title=Peptides_for_Transfection"/>
	<link rel="alternate" type="text/html" href="https://eln.excellgen.com/index.php?title=Peptides_for_Transfection&amp;action=history"/>
	<updated>2026-10-19T12:58:02Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://eln.excellgen.com/index.php?title=Peptides_for_Transfection&amp;diff=17782&amp;oldid=prev</id>
		<title>Paul.xu at 19:27, 22 April 2018</title>
		<link rel="alternate" type="text/html" href="https://eln.excellgen.com/index.php?title=Peptides_for_Transfection&amp;diff=17782&amp;oldid=prev"/>
		<updated>2018-04-22T19:27:50Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== pH responsive LAH4- L1 peptide&amp;amp;nbsp; ==&lt;br /&gt;
&lt;br /&gt;
[https://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b00338&amp;amp;nbsp https://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b00338&amp;amp;nbsp];&lt;br /&gt;
&lt;br /&gt;
https://www.nature.com/articles/s41598-017-10049-y&lt;br /&gt;
&lt;br /&gt;
{| border=&amp;quot;1&amp;quot; cellspacing=&amp;quot;1&amp;quot; cellpadding=&amp;quot;1&amp;quot; style=&amp;quot;width:600px;&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| Peptide&amp;lt;br/&amp;gt;&lt;br /&gt;
| NLS&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| Diameter ± SD (nm)&amp;amp;nbsp;&lt;br /&gt;
| Zeta Potential ± SD (mV)&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| Transfection Efficiency&lt;br /&gt;
|-&lt;br /&gt;
| LAH4-L1&amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| KKALLAHALHLLALLALHLAHALKKA&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| 226.7 ± 31.7&amp;lt;br/&amp;gt;&lt;br /&gt;
| +2.2 ± 0.9&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| low&lt;br /&gt;
|-&lt;br /&gt;
| PK1-LAH4-L1 (PK1)&amp;lt;br/&amp;gt;&lt;br /&gt;
| SV40&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| PKKKRKVG CG KKALLAHALHLLALLALHLAHALKKA&amp;lt;br/&amp;gt;&lt;br /&gt;
| 164.9 ± 1.3&amp;lt;br/&amp;gt;&lt;br /&gt;
| +10.1 ± 2.1&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| High&lt;br /&gt;
|-&lt;br /&gt;
| PK2-LAH4-L1 (PK2)&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| Reversed SV40&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| VKRKKKPG CG KKALLAHALHLLALLALHLAHALKKA&amp;lt;br/&amp;gt;&lt;br /&gt;
| 130.1 ± 1.1&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| +13.3 ± 1.6&amp;amp;nbsp;&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| High++&lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
KR-LAH4-L1&amp;amp;nbsp; (KR)&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
| Nucleoplasmin&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| &lt;br /&gt;
KRPAATKKAGQAKKKKG CG KKALLAHALHLLALLAL HLAHALKKA&lt;br /&gt;
&lt;br /&gt;
| 184.6 ± 6.8&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| +24.2 ± 0.9&amp;amp;nbsp;&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| high&lt;br /&gt;
|-&lt;br /&gt;
| NQ-LAH4-L1 (NQ)&amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| NQSSNFGPMKGGNFGGRSSGPYGGGGQYFAKPRNQG GYG CG KKALLAHALHLLALLALHLAHALKKA&amp;lt;br/&amp;gt;&lt;br /&gt;
| 354.5 ± 81.5&amp;lt;br/&amp;gt;&lt;br /&gt;
| N.A.&amp;amp;nbsp;&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| SV40&amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| PKKKRKV&amp;lt;br/&amp;gt;&lt;br /&gt;
| 563.3&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| −3.67&amp;amp;nbsp;&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| no&lt;br /&gt;
|-&lt;br /&gt;
| CSV40C&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| CPKKKRKVC&amp;lt;br/&amp;gt;&lt;br /&gt;
| 235.8&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| 4.1&amp;lt;br/&amp;gt;&lt;br /&gt;
| no&lt;br /&gt;
|-&lt;br /&gt;
| STR-CSV40C*&amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| CH3(CH2)16-CONH-CPKKKRKVC&amp;lt;br/&amp;gt;&lt;br /&gt;
| 85.0&amp;lt;br/&amp;gt;&lt;br /&gt;
| 33.0&amp;lt;br/&amp;gt;&lt;br /&gt;
| high&lt;br /&gt;
|-&lt;br /&gt;
| STR-CH2SV40H2C *&amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| CH3(CH2)16-CONH-CHHPKKKRKVHHC&amp;lt;br/&amp;gt;&lt;br /&gt;
| 89.2&amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;span style=&amp;quot;color: rgb(69, 69, 69); font-family: robotoregular, Meiryo; text-align: center;&amp;quot;&amp;gt;29.1&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt;&lt;br /&gt;
| high+&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*STR was conjugated to the N-terminal of CSV40C and&amp;amp;nbsp;STR-CH2SV40H2C &amp;amp;nbsp;using the solid-phase peptide synthesis method.&lt;br /&gt;
&lt;br /&gt;
DNA transfection. A549, Calu-3, RAW264.7 and JAWSII cells were transfected with peptide/DNA complexes at 1 µg luciferase plasmid per well in 24-well plates. Lipofectamine™ 2000 was used as control. The complexes were prepared at 5:1, 10:1 and 15:1 ratios (w/w) in Opti-MEM I reduced serum medium. The cells were transfected when they reached 70-80% confluency. After 5 h of incubation with the complexes at 37 °C, the transfection media were removed and replaced with serum supplemented cell culture media. At 24 h post-transfection, the cells were rinsed and lysed in 100 µl reporter lysis buffer. The luciferase expression was detected using the luciferase assay system according to the manufacturer&amp;#039;s protocol. The results were expressed as relative light unit (RLU) per mg of total protein. For transfection with growth-arrested cells, the standard double thymidine block method was employed as previously reported.32 A549 cells were seeded at a density of 5 × 104 cells per well in 24-well plate for overnight. The cell culture medium was then replaced with one containing thymidine (2mM). After 19 h of incubation, the cells were washed and incubated with thymidine-free culture medium. After 9 h, thymidine was added to the culture medium and the cells were incubated for a further 17 h. The cells were washed again. Peptide/DNA complexes prepared in Opti-MEM I reduced serum medium containing thymidine were added to the cells. After 5 h of incubation, the transfection medium was removed and replaced with fresh culture medium. The luciferase expression was examined at 24 h post-transfection as described above.&lt;br /&gt;
&lt;br /&gt;
== List of NLS&amp;amp;nbsp; ==&lt;br /&gt;
&amp;lt;div&amp;gt;NLSAnnotation&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRx{10}KKKLNucleoplasmin&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PKKKRKVSV40,LrgT&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PKKNRLRRPBRCA1&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PKRPRDRHDGELGGRKRARGVirD2-Cterm&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PLLKKIKQc-myb&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PNKKKRKSV40(VP2)&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PPQKKIKSN-myc&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PPRIYPQLPSAPTBDV-P&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PPRKKRTVVNS5A&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PPVKRERTSRanBP3&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PQPKKKPp53&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PQSRKKLRMax&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PRGRRQPIPKARQPHCV&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PRPRKIPRBDV-P&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PRRGPRHCV&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PRRRKSOX9&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PYLNKRKGKPPho4p&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PKKAREDpolyoma&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PAKRARRGYKCPVcapsid&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRx{7,9}PQPKKKPp53-NLS1&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KSKKKAQHIV1423&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KTRKHRGL29&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KVNSRKRRKEVPGPNGATEEDCTP&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KVTKRKHDNEGSGSKRPKhum-Ku70&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;K[RK]{3,5}x{11,18}[RK]Kx{2,3}K&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;LEKKVKKKFDWCAprot.Hsci&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;LKDVRKRKLGPGHDNAseEBV&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;LKRKLQRPax-QNR&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;LKRPRSPSSEBNA1&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;MAPSAKATAAKKAVVKGTNGKKALKVRTSATFRLPKTLKLARL25&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;MNKIPIKDLLNPGMat-alpha&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;MPKTRRRPRRSQRKRPPTRex&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;MPTEERVRKRKESNRESARRSRYRKAAHLKopaque2&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;NQSSNFGPMKGGNFGGRSSGPYGGGGQYFAKPRNQGGYM9&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;PAAKRVKLDlscMyc&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;QRKRQKNF-kB&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RAIKRRPGLDFDDDGEGNSKFLRhARNT&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;REKKEKEQKEKCAprot.Hsc9&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RRPSx{22}RRKRQPK-A&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RRRx{11}KRRKCBP80&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RRSMKRKhVDR&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RVHPYQRQKI-5&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;SANKVTKNKSNSSPYLNKRGKPGPDSPho4&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;SDKKVRSRLIECATa.alpha&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;SKRVAKRKLc-erb-A&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;SxGTKRSYxxMFluA&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;TEKK[QG]KSILYDCAprot.Hsc3&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;TKRSxxxMinfluenzaNP&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;VNEAFETLKRCMyoD&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;VSRKRPRpolyoma&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;YKRPCKRSFIRFIDNAseEBV&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;YLTQETNKVETYKEQPLKTPGKKKKGKPPTHrP&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;YNNQSSNFGPMKGGNM9&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;[KAR]TPIQKHWRPTVLTEGPPVKIRIETGEWE[KA]ASVintegrase&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RRMKWKKPDX-1&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RRKGKEKHunt.Dis.pro&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RGRRRRQRAmida&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RIRKKLRp54&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RKCLQAGMNLEARKTKKhGlu.cort.&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RKEWLTNFMEDRRQRKLhDNAtopoII&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RKKRKx{9}KAKKSKN1N2&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RKKRRQRRRHIV-1Tat&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RKRAFHGDDPFGEGPPDKKICP-8&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RKRIREDRKATTAQKVQQMKQRLNENERKRKRTCPTP&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RKRKKystDNApolalpha&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RKRKKMPASQRSKRRKThBLM&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RKRRRAmida&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RLKKLKCSKx{19}KTKRGAL4&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RPRRKSRY&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RQARRNRRRRWRHIV-1Rev&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RRERNKMAAAKCRNRRRcFOS&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;RRERx{4}RPRKIPRBDV-P&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;[KR]{4}x{20,24}K{1,4}xK&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KKKRERLDRCP&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRKRRPBRCA1&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;IKYFKKFPKDyeast,SKI3&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;HRKYEAPRHx{6}PRKRL3&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRKx{11}KKKSKKhpoly(ADP)poly&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;HRIEEKRKRTYETFKSINF-kB&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRKx{22}KELQKQITKHIV-1&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRMRNRIAASKCRKRKLcJUN&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRPAATKKAGQAKKKKNucloplasmin&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;EEDGPQKKKRRLpolyomaVP2&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRPACTLKPECVQQLLVCSQEAKKHCDA&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRPAEDMEEEQAFKRSRhumKprotein&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRPMNAFIVWSRDQRRKSRY&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRPMNAFMVWAQAARRKSOX9&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRKKEMANKSAPEAKKKKNucleolin&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;APKRKSGVSKCpolyomaVP1&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRAAEDDEDDDVDTKKQKhProTalpha&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KKKRRSREKTCF-1&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KKKKKEEEGEGKKKact/inh,betaA&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KKKYKLKHIV1422&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KKQTTLAFKPIKKGKKRhDNAtopoII&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;CKRKTTNADRRKAMyoD&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KKEKKKSKKdyskerin&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KHRKHPGL29&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRx{9}KTKKTHOV&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;CYGSKNTGAKKRKIDDA&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KKSKKGRQEALERLKKAhDNApolalpha&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KDCVINKHHRNRCQYCRLQRTR2&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KAKRQRv-Rel&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KKx{15}KKRKDNAhelicaseQ1&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;EYLSRKGKLELVirD2-Nterm&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRQRx{20}KKSKKMitosin&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRSAEGGNPPKPLKKLRp110RB1&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;APTKRKGSSV40()VP1&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KKKKRKREKLEF-1&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;KRPRPadenovE1a&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;GRKRKKRTTst1/Oct6&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;HKKKKIRTSPTFTTPKTLRLRRQPKYPRKSAPRRNKLDHYBIB&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;GGGx{3}KNRRx{6}RGGRNNab2&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;GKKRSKAH2B&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;GKKKYKLKHHIV-1&amp;lt;/div&amp;gt;&lt;/div&gt;</summary>
		<author><name>Paul.xu</name></author>
	</entry>
</feed>